Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) was the target of a large decline in short interest during the month of July. As of July 15th, there was short interest totalling 3,000,000 shares, a decline of 8.0% from the June 30th total of 3,260,000 shares. Based on an average daily trading volume, of 524,000 […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) COO Peter Radovich sold 1,425 shares of the business’s stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $25.65, for a total value of $36,551.25. Following the completion of the transaction, the chief operating officer now directly owns […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) COO Peter Radovich sold 1,425 shares of Mirum Pharmaceuticals stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $25.65, for a total value of $36,551.25. Following the completion of the sale, the chief operating officer now owns 37,675 shares of […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) COO Peter Radovich sold 1,425 shares of Mirum Pharmaceuticals stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $25.65, for a total transaction of $36,551.25. Following the transaction, the chief operating officer now owns 37,675 shares in the […]